SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT South East SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11246
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology consulting and licensing services. It also manages the portfolios of intellectual property of several organizations. The company offers services in areas of digital and connected information society, health and life technologies; environment, energy and territories, industrial processing, and culture, heritage and digital humanities. It serves materials, environment and information technologies such as hardware and embedded, multimedia, data processing, software engineering, chemistry process, material and mechanical engineering, energy, optical, environment and other sectors. SATT South East is headquartered in Marseille, France.

SATT South East SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SATT South East SAS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Licensing Agreements 13
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS – Key Competitors 18
SATT South East SAS – Key Employees 19
SATT South East SAS – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SATT South East SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS, Key Competitors 18
SATT South East SAS, Key Employees 19

List of Figures
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Graham Holdings Company:企業の戦略・SWOT・財務分析
    Graham Holdings Company - Strategy, SWOT and Corporate Finance Report Summary Graham Holdings Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aplus Financial Co Ltd.:企業の戦略・SWOT・財務情報
    Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Solvay SA (SOLB)-エネルギー分野:企業M&A・提携分析
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates, vinyls and acetate tow. Its products include chemical products such as barium stron …
  • IntegraGen SA (ALINT):企業の財務・戦略的SWOT分析
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • EMCORE Corporation (EMKR):企業の財務・戦略的SWOT分析
    EMCORE Corporation (EMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Banco ABC Brasil SA (ABCB4):企業の財務・戦略的SWOT分析
    Banco ABC Brasil SA (ABCB4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sea Run Holdings Inc:製品パイプライン分析
    Summary Sea Run Holdings Inc (Sea Run Holdings) is a healthcare solutions provider that discovers and develops innovative reagents and therapeutics. The company’s pipeline products include salmon plasma and salmon fibrin products. Its salmon plasma product provides effective treatment for acute pain …
  • Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glyco …
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • Mobile Telesystems:企業の戦略・SWOT・財務分析
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EXINI Diagnostics AB:医療機器:M&Aディール及び事業提携情報
    Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare technology company that offers development of software solutions for the medical diagnostic market. The company offers aBSI, a web application used by trained healthcare professionals and researchers …
  • Booz Allen Hamilton Holding Corp (BAH):企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corp (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Westell Technologies Inc (WSTL):企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) is a communication service company that provides wireless infrastructure solutions. The company offers in-building wireless, intelligent site management and communication network solutions. The company’sin-building wireless include antennas, distributed ant …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Hannover Ruck SE:企業の戦略・SWOT・財務情報
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Firmenich SA:企業の戦略的SWOT分析
    Firmenich SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Avraham Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Avraham Pharmaceuticals Ltd (Avraham Pharmaceuticals) is a pharmaceutical company that develops novel products for treatment and prevention of neurodegenerative disorders. The company offers a product, Ladostigil. It offers product in the therapeutic area of mild cognitive impairment. Avraha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆